Merck Tbk PT

Merck Tbk PT OCF Margin

The Operating Cash Flow Margin of Merck Tbk PT (MERK.JK) as of Oct 17, 2026 is 31.36 %. In the previous year, Operating Cash Flow Margin was 5.37 % — a change of 483.57% (higher).

OCF Margin

31.36 %

YoY

483.57%

Last updated:

Operating Cash Flow Margin of Merck Tbk PT is 2025 31.36 % . Operating Cash Flow Margin of Merck Tbk PT was 2024 5.37 % . It decreases by 483.57% higher compared to the previous year.

The Merck Tbk PT OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
27.61 IDR
Jan 1, 2019
-28.32 IDR
Jan 1, 2020
10.98 IDR
Jan 1, 2021
15.95 IDR
Jan 1, 2022
9.81 IDR
Jan 1, 2023
21.21 IDR
Jan 1, 2024
5.37 IDR
Jan 1, 2025
31.36 IDR
The Merck Tbk PT OCF Margin history
YEAROCF MarginYoY
31.36 %+483.57%
5.37 %-74.66%
21.21 %+116.16%
9.81 %-38.51%
15.95 %+45.36%
10.98 %-138.76%
-28.32 %-202.55%
27.61 %+145.81%
11.23 %+165.38%
4.23 %-74.10%
16.34 %-39.42%
26.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT is a pharmaceutical company based in Jakarta Timur, DKI Jakarta, operating within the Health Care sector. The company, listed on the Indonesian stock exchange with ticker MERK.JK and ISIN ID1000136609, has been publicly traded since its IPO on July 23, 1981. It employs 376 full-time staff and focuses on the development and distribution of pharmaceutical and chemical products. The company operates through three business segments: Biopharma, which covers ethical pharmaceutical products; Consumer Health, which includes over-the-counter products; and Others, which encompasses additional business activities. Merck Tbk PT is committed to providing personalized treatments for serious diseases and supports initiatives related to reproductive health, including enabling individuals to achieve their goal of becoming parents. The company's official website is https://www.merckgroup.com/id-id, where further information about its operations and services can be accessed. As a publicly listed entity, Merck Tbk PT is subject to regulatory disclosures and financial reporting requirements in Indonesia. The company's primary focus remains on delivering healthcare solutions through its pharmaceutical and chemical offerings, targeting both professional medical markets and consumer health needs. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

Operating Cash Flow Margin of Merck Tbk PT is 31.36 % in 2025.

Operating Cash Flow Margin of Merck Tbk PT changed from 5.37 % to 31.36 %, representing a 483.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Merck Tbk PT with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Merck Tbk PT

All Key Metrics — Merck Tbk PT